Reduction of cisplatin-induced emesis by a selective neurokinin-1-receptor antagonist. L-754,030 Antiemetic Trials Group. | N Engl J Med;340(3): 190-5, 1999 Jan 21. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Reduction of cisplatin-induced emesis by a selective neurokinin-1-receptor antagonist. L-754,030 Antiemetic Trials Group.

Navari, R M; Reinhardt, R R; Gralla, R J; Kris, M G; Hesketh, P J; Khojasteh, A; Kindler, H; Grote, T H; Pendergrass, K; Grunberg, S M; Carides, A D; Gertz, B J.

Affiliation

Navari RM; Simon-Williamson Clinic, Birmingham, Ala, USA.

N Engl J Med ; 340(3): 190-5, 1999 Jan 21.

Article in En | MEDLINE | ID: mdl-9917226

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Vomiting / Morpholines / Cisplatin / Neurokinin-1 Receptor Antagonists / Acetals / Antiemetics Type of study: Clinical_trials Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: N Engl J Med Year: 1999 Document type: Article Affiliation country: Country of publication:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Vomiting / Morpholines / Cisplatin / Neurokinin-1 Receptor Antagonists / Acetals / Antiemetics Type of study: Clinical_trials Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: N Engl J Med Year: 1999 Document type: Article Affiliation country: Country of publication: